Acutaas Chemicals Ltd. Fundamental Analysis (NSE: ACUTAAS.NS)
Acutaas Chemicals Ltd. Fundamental Analysis (NSE: ACUTAAS.NS)
Acutaas Chemicals Ltd. (NSE: ACUTAAS.NS) shows strong financial fundamentals with a PE ratio of 74.91, profit margin of 26.60%, and ROE of 25.01%. The company generates $13.4B in annual revenue with strong year-over-year growth of 40.34%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 83.9/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze ACUTAAS.NS's fundamental strength across five key dimensions:
Efficiency Score
ExcellentACUTAAS.NS demonstrates superior asset utilization.
Valuation Score
WeakACUTAAS.NS trades at a premium to fair value.
Growth Score
ExcellentACUTAAS.NS delivers strong and consistent growth momentum.
Financial Health Score
ExcellentACUTAAS.NS maintains a strong and stable balance sheet.
Profitability Score
ModerateACUTAAS.NS maintains healthy but balanced margins.
Key Financial Metrics
Is ACUTAAS.NS Expensive or Cheap?
P/E Ratio
ACUTAAS.NS trades at 74.91 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, ACUTAAS.NS's PEG of 2.13 indicates potential overvaluation.
Price to Book
The market values Acutaas Chemicals Ltd. at 16.14 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 55.57 times EBITDA. This signals the market has high growth expectations.
How Well Does ACUTAAS.NS Make Money?
Net Profit Margin
For every $100 in sales, Acutaas Chemicals Ltd. keeps $26.60 as profit after all expenses.
Operating Margin
Core operations generate 36.35 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $25.01 in profit for every $100 of shareholder equity.
ROA
Acutaas Chemicals Ltd. generates $17.96 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Acutaas Chemicals Ltd. produces operating cash flow of $1.36B, showing steady but balanced cash generation.
Free Cash Flow
Acutaas Chemicals Ltd. generates weak or negative free cash flow of $-46.48M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.57 in free cash annually.
FCF Yield
ACUTAAS.NS converts -0.02% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
74.91
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
2.13
vs 25 benchmark
P/B Ratio
Price to book value ratio
16.14
vs 25 benchmark
P/S Ratio
Price to sales ratio
19.92
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.02
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.82
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.25
vs 25 benchmark
ROA
Return on assets percentage
0.18
vs 25 benchmark
ROCE
Return on capital employed
0.28
vs 25 benchmark
How ACUTAAS.NS Stacks Against Its Sector Peers
| Metric | ACUTAAS.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 74.91 | 27.38 | Worse (Expensive) |
| ROE | 25.01% | 967.00% | Weak |
| Net Margin | 26.60% | -1512.00% (disorted) | Strong |
| Debt/Equity | 0.02 | 0.64 | Strong (Low Leverage) |
| Current Ratio | 3.82 | 3.17 | Strong Liquidity |
| ROA | 17.96% | 554.00% | Weak |
ACUTAAS.NS outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Acutaas Chemicals Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
65.19%
Industry Style: Cyclical, Commodity, Value
High GrowthEPS CAGR
127.16%
Industry Style: Cyclical, Commodity, Value
High GrowthFCF CAGR
71.84%
Industry Style: Cyclical, Commodity, Value
High Growth